Applied Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Applied Therapeutics

11/05/2023 13:21

* Applied Therapeutics Inc  APLT.OQ  reported a quarterly
adjusted
loss of 18 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 31 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Applied Therapeutics Inc's reported EPS for the quarter
was a
loss of 18 cents​.
    * The mean earnings estimate of analysts had risen by
about 28.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Applied Therapeutics Inc shares had risen by 103.4% this
quarter and gained 117.1% so far this year.
    * The company reported a quarterly loss of $10.14 million.
    * Wall Street's median 12-month price target for Applied
Therapeutics Inc is $5.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 12:21 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.31          -0.18          Beat
 Dec. 31 2022      -0.46          -0.16          Beat
 Sep. 30 2022      -0.48          -0.40          Beat
 Jun. 30 2022      -0.78          -0.80          Missed